Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ankyrin repeat domain 20 family member A2 pseudogene (ENSG00000279381, ANKRD20A2P) is a genomic sequence that resembles the functional ankyrin repeat domain 20 family member A2 gene but does not code for a functional protein due to disabling mutations or lack of regulatory sequences[1][5][7]. Pseudogenes like ANKRD20A2P are generally considered nonfunctional remnants of evolutionarily duplicated or processed genes and are not known to have therapeutic, diagnostic, or regulatory function in human biology[4]. There are no disease associations, drug interactions, mechanisms of action, or known roles as biomarkers for this specific pseudogene. This entry is not a suitable therapeutic target; it is a nonfunctional pseudogene, not a gene encoding a functional protein[1][7][5][4].
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ankyrin repeat domain 20 family member A2 pseudogene (ANKRD20A2P).